CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk

Atsushi Oda, Hans D. Ochs, Laurence A. Lasky, Susan Spencer, Katsutoshi Ozaki, Mitsuhiro Fujihara, Makoto Handa, Kenji Ikebuchi, Hisami Ikeda

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Wiskott-Aldrich syndrome (WAS) and X-linked thrombocytopenia are caused by mutations of the WAS protein (WASP) gene. WASP may be involved in the regulation of podosome, an actin-rich dynamic cell adhesion structure formed by various types of cells. The molecular links between WASP and podosomes or other cell adhesion structures are unknown. Platelets express an SH2-SH3 adapter molecule, CrkL, that can directly associate with paxillin, which is localized in podosomes. The hypothesis that CrkL binds to WASP was, therefore, tested. Results from coprecipitation experiments using anti-CrkL and GST-fusion proteins suggest that CrkL binds to WASP through its SH3 domain and that the binding was not affected by WASP tyrosine phosphorylation. The binding of GST-fusion SH3 domain of PSTPIP1 in vitro was also not affected by WASP tyrosine phosphorylation, suggesting that the binding of the SH3 domains to WASP is not inhibited by tyrosine phosphorylation of WASP. Anti-CrkL also coprecipitates a 72-kd protein, which was identified as syk tyrosine kinase, critical for collagen induced-platelet activation. CrkL immunoprecipitates contain kinase-active syk, as evidenced by an in vitro kinase assay. Coprecipitation experiments using GST-fusion CrkL proteins suggest that both SH2 and SH3 domains of CrkL are involved in the binding of CrkL to syk. WASP, CrkL, syk, and paxillin-like Hic-5 incorporated to platelet cytoskeleton after platelet aggregation. Thus, CrkL is a novel molecular adapter for WASP and syk and may potentially transfer these molecules to the cytoskeleton through association with cytoskeletal proteins such as Hic-5.

Original languageEnglish
Pages (from-to)2633-2639
Number of pages7
JournalBlood
Volume97
Issue number9
DOIs
Publication statusPublished - 2001 May 1

Fingerprint

Wiskott-Aldrich Syndrome Protein
src Homology Domains
Proteins
Platelets
Phosphorylation
Paxillin
Tyrosine
Fusion reactions
Cell adhesion
Coprecipitation
Cytoskeleton
Cell Adhesion
Phosphotransferases
Blood Platelets
Wiskott-Aldrich Syndrome
Molecules
Cytoskeletal Proteins
Platelet Activation

ASJC Scopus subject areas

  • Hematology

Cite this

Oda, A., Ochs, H. D., Lasky, L. A., Spencer, S., Ozaki, K., Fujihara, M., ... Ikeda, H. (2001). CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood, 97(9), 2633-2639. https://doi.org/10.1182/blood.V97.9.2633

CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. / Oda, Atsushi; Ochs, Hans D.; Lasky, Laurence A.; Spencer, Susan; Ozaki, Katsutoshi; Fujihara, Mitsuhiro; Handa, Makoto; Ikebuchi, Kenji; Ikeda, Hisami.

In: Blood, Vol. 97, No. 9, 01.05.2001, p. 2633-2639.

Research output: Contribution to journalArticle

Oda, A, Ochs, HD, Lasky, LA, Spencer, S, Ozaki, K, Fujihara, M, Handa, M, Ikebuchi, K & Ikeda, H 2001, 'CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk', Blood, vol. 97, no. 9, pp. 2633-2639. https://doi.org/10.1182/blood.V97.9.2633
Oda A, Ochs HD, Lasky LA, Spencer S, Ozaki K, Fujihara M et al. CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood. 2001 May 1;97(9):2633-2639. https://doi.org/10.1182/blood.V97.9.2633
Oda, Atsushi ; Ochs, Hans D. ; Lasky, Laurence A. ; Spencer, Susan ; Ozaki, Katsutoshi ; Fujihara, Mitsuhiro ; Handa, Makoto ; Ikebuchi, Kenji ; Ikeda, Hisami. / CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. In: Blood. 2001 ; Vol. 97, No. 9. pp. 2633-2639.
@article{c8e441ecbf764cfaaa92ef7e8db9d28e,
title = "CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk",
abstract = "Wiskott-Aldrich syndrome (WAS) and X-linked thrombocytopenia are caused by mutations of the WAS protein (WASP) gene. WASP may be involved in the regulation of podosome, an actin-rich dynamic cell adhesion structure formed by various types of cells. The molecular links between WASP and podosomes or other cell adhesion structures are unknown. Platelets express an SH2-SH3 adapter molecule, CrkL, that can directly associate with paxillin, which is localized in podosomes. The hypothesis that CrkL binds to WASP was, therefore, tested. Results from coprecipitation experiments using anti-CrkL and GST-fusion proteins suggest that CrkL binds to WASP through its SH3 domain and that the binding was not affected by WASP tyrosine phosphorylation. The binding of GST-fusion SH3 domain of PSTPIP1 in vitro was also not affected by WASP tyrosine phosphorylation, suggesting that the binding of the SH3 domains to WASP is not inhibited by tyrosine phosphorylation of WASP. Anti-CrkL also coprecipitates a 72-kd protein, which was identified as syk tyrosine kinase, critical for collagen induced-platelet activation. CrkL immunoprecipitates contain kinase-active syk, as evidenced by an in vitro kinase assay. Coprecipitation experiments using GST-fusion CrkL proteins suggest that both SH2 and SH3 domains of CrkL are involved in the binding of CrkL to syk. WASP, CrkL, syk, and paxillin-like Hic-5 incorporated to platelet cytoskeleton after platelet aggregation. Thus, CrkL is a novel molecular adapter for WASP and syk and may potentially transfer these molecules to the cytoskeleton through association with cytoskeletal proteins such as Hic-5.",
author = "Atsushi Oda and Ochs, {Hans D.} and Lasky, {Laurence A.} and Susan Spencer and Katsutoshi Ozaki and Mitsuhiro Fujihara and Makoto Handa and Kenji Ikebuchi and Hisami Ikeda",
year = "2001",
month = "5",
day = "1",
doi = "10.1182/blood.V97.9.2633",
language = "English",
volume = "97",
pages = "2633--2639",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "9",

}

TY - JOUR

T1 - CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk

AU - Oda, Atsushi

AU - Ochs, Hans D.

AU - Lasky, Laurence A.

AU - Spencer, Susan

AU - Ozaki, Katsutoshi

AU - Fujihara, Mitsuhiro

AU - Handa, Makoto

AU - Ikebuchi, Kenji

AU - Ikeda, Hisami

PY - 2001/5/1

Y1 - 2001/5/1

N2 - Wiskott-Aldrich syndrome (WAS) and X-linked thrombocytopenia are caused by mutations of the WAS protein (WASP) gene. WASP may be involved in the regulation of podosome, an actin-rich dynamic cell adhesion structure formed by various types of cells. The molecular links between WASP and podosomes or other cell adhesion structures are unknown. Platelets express an SH2-SH3 adapter molecule, CrkL, that can directly associate with paxillin, which is localized in podosomes. The hypothesis that CrkL binds to WASP was, therefore, tested. Results from coprecipitation experiments using anti-CrkL and GST-fusion proteins suggest that CrkL binds to WASP through its SH3 domain and that the binding was not affected by WASP tyrosine phosphorylation. The binding of GST-fusion SH3 domain of PSTPIP1 in vitro was also not affected by WASP tyrosine phosphorylation, suggesting that the binding of the SH3 domains to WASP is not inhibited by tyrosine phosphorylation of WASP. Anti-CrkL also coprecipitates a 72-kd protein, which was identified as syk tyrosine kinase, critical for collagen induced-platelet activation. CrkL immunoprecipitates contain kinase-active syk, as evidenced by an in vitro kinase assay. Coprecipitation experiments using GST-fusion CrkL proteins suggest that both SH2 and SH3 domains of CrkL are involved in the binding of CrkL to syk. WASP, CrkL, syk, and paxillin-like Hic-5 incorporated to platelet cytoskeleton after platelet aggregation. Thus, CrkL is a novel molecular adapter for WASP and syk and may potentially transfer these molecules to the cytoskeleton through association with cytoskeletal proteins such as Hic-5.

AB - Wiskott-Aldrich syndrome (WAS) and X-linked thrombocytopenia are caused by mutations of the WAS protein (WASP) gene. WASP may be involved in the regulation of podosome, an actin-rich dynamic cell adhesion structure formed by various types of cells. The molecular links between WASP and podosomes or other cell adhesion structures are unknown. Platelets express an SH2-SH3 adapter molecule, CrkL, that can directly associate with paxillin, which is localized in podosomes. The hypothesis that CrkL binds to WASP was, therefore, tested. Results from coprecipitation experiments using anti-CrkL and GST-fusion proteins suggest that CrkL binds to WASP through its SH3 domain and that the binding was not affected by WASP tyrosine phosphorylation. The binding of GST-fusion SH3 domain of PSTPIP1 in vitro was also not affected by WASP tyrosine phosphorylation, suggesting that the binding of the SH3 domains to WASP is not inhibited by tyrosine phosphorylation of WASP. Anti-CrkL also coprecipitates a 72-kd protein, which was identified as syk tyrosine kinase, critical for collagen induced-platelet activation. CrkL immunoprecipitates contain kinase-active syk, as evidenced by an in vitro kinase assay. Coprecipitation experiments using GST-fusion CrkL proteins suggest that both SH2 and SH3 domains of CrkL are involved in the binding of CrkL to syk. WASP, CrkL, syk, and paxillin-like Hic-5 incorporated to platelet cytoskeleton after platelet aggregation. Thus, CrkL is a novel molecular adapter for WASP and syk and may potentially transfer these molecules to the cytoskeleton through association with cytoskeletal proteins such as Hic-5.

UR - http://www.scopus.com/inward/record.url?scp=0035353161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035353161&partnerID=8YFLogxK

U2 - 10.1182/blood.V97.9.2633

DO - 10.1182/blood.V97.9.2633

M3 - Article

C2 - 11313252

AN - SCOPUS:0035353161

VL - 97

SP - 2633

EP - 2639

JO - Blood

JF - Blood

SN - 0006-4971

IS - 9

ER -